What is LOPJLB’s current signal on REVB?

LOPJLB’s latest quantitative signal on Revelation Biosciences, Inc. (REVB) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is REVB in?

Revelation Biosciences, Inc. (REVB) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Revelation Biosciences, Inc. (REVB) do?

Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting the immune system. The company's therapeutic pipeline includes promising candidates such as GEM-AKI, which is being developed as a potential therapy for both the prevention and management of acute ki…

Where is Revelation Biosciences, Inc. based / listed?

Revelation Biosciences, Inc. is based in US, listed on NASDAQ.

Revelation Biosciences, Inc. (REVB)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.77-7.23%Close

SELLCRISIS · day 11

[SCORES & PROFILE]

FUND: 13
VALUE: 20
GROWTH: 47
GARP: 6
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-60.1%

REV YoY-

ROE-100.2%

EPS YoY-

ROA-86.0%

GROSS

NET

[VALUATION]

P/E TTM-0.11

P/E FWD-

SECTOR PE20.12

INDUSTRY PE13.79

P/B0.29

P/FCF-

EV/EBITDA0.72

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E7.35

ALTMAN Z-

CURR RATIO6.21

ND/EBITDA-

BETA-0.17

Revelation Biosciences, Inc. (REVB)

Key stats

Prediction markets

FUNDAMENTALS

Company news